newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics Reports First Quarter Financial Results and Business Updates

CNTY-813, Century's type 1 diabetes iPSC-derived islet therapy with functional-cure potential, remains on track for IND in 4Q 2026; initial clinical data expected in 2H 2027Upcoming oral presentation at the American